Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trialAnchalee Avihingsanon, Taisheng Li, Jared M. Baeten et al.|The Lancet HIV|2023Cited by 62
[Effects of traditional Chinese medicine on CD4 + T cell counts and HIV viral loads during structured treatment interruption in highly active antiretroviral therapy].Hongxin Zhao, Hongshan Wei, Jun Yao et al.|PubMed|2006Cited by 3
[HIV-1 genotypic resistance profiles in children failing highly active antiretroviral therapy].Zhiying Liu, Fujie Zhang, Hongshan Wei et al.|PubMed|2007Cited by 1
[Influencing factors of single-platform method of flow cytometry in the detection of immunophenotype of peripheral blood lymphocytes in HIV/AIDS patients].Fujie Zhang, Hua Lin, Jun Yao et al.|PubMed|2005Cited by 0